News

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
Steven Hatfill promoted hydroxychloroquine during the pandemic. Decades earlier he was wrongly connected with the anthrax ...
A former White House adviser who pushed malaria drugs as a treatment for COVID-19 long after the FDA had ruled them out has ...